Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9185476 | Thrombosis Research | 2005 | 13 Pages |
Abstract
rFVIIa may be beneficial in the short-term management of life threatening bleeding in some children with liver disease. This effect may be further enhanced with the additional use of octreotide. Furthermore, rFVIIa is useful for prophylaxis at invasive procedures, even without additional treatment with fresh frozen plasma. The possible risk of portal vein thrombosis needs to be considered.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Maria Pettersson, Björn Fischler, Pia Petrini, Sam Schulman, Antal Nemeth,